Dr. Reddy’s (NYSE: RDY) allots 12,665 ESOP shares to employees

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited has allotted 12,665 equity shares of Re.1 each on February 17, 2026 to eligible employees following the exercise of stock options. These options were granted under the Dr. Reddy’s Employees Stock Options Scheme, 2002 and the Employees ADR Stock Option Scheme, 2007.

The shares were exercised at prices ranging from Re.1 to Rs. 735.80 per share, and the new shares rank pari passu with existing equity shares. After this allotment, total issued shares are 83,46,44,020 and total issued share capital is Rs. 83,46,44,020, with paid-up capital of 83,46,43,020 equity shares of Re.1 each.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

February, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   x                             Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                             No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated Februaruy 17, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED
	(Registrant)
Date: February 17, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

	Dr. Reddy's Laboratories Ltd.
	8-2-337, Road No. 3, Banjara Hills
	Hyderabad – 500 034, Telangana, India
	CIN: L85195TG1984PLC004507
	Tel:  + 91 40 4900 2900
	Fax:  + 91 40 4900 2999
	Email: mail@drreddys.com
	Web: www.drreddys.com

February 17, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs

This is to inform you that the Company has allotted 12,665 equity shares of Re.1/- each of the Company, fully paid up, on February 17, 2026, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy’s Employees Stock Options Scheme, 2002 and Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.

Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

Encl: as above

	Dr. Reddy's Laboratories Ltd.
	8-2-337, Road No. 3, Banjara Hills
	Hyderabad – 500 034, Telangana, India
	CIN: L85195TG1984PLC004507
	Tel:  + 91 40 4900 2900
	Fax:  + 91 40 4900 2999
	Email: mail@drreddys.com
	Web: www.drreddys.com

Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

1	Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad – 500034
2	Name of the Stock Exchanges on which the company’s shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3	Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4	Filing Number, if any: NA
5	Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy’s Employees Stock Options Scheme, 2002 and Dr. Reddy’s Employees ADR Stock Option Scheme, 2007.
6	Kind of security to be listed: Equity Shares
7	Par value of the shares: Re. 1/-
8	Date of issue of shares: February 17, 2026 (Date of allotment on exercise)
9	Number of shares issued:  12,665 equity shares
10	Share Certificate No., if applicable: NA
11	Distinctive number of the share, if applicable: 834630356 to 834643020
12	ISIN Number of the shares if issued in Demat: INE089A01031
13	Exercise price per share: i.              5,115 equity shares exercised at Re.1/- per share ii.             1,300 equity shares exercised at Rs. 735.80/- per share iii.            6,250 equity shares exercised at Rs. 521.40/- per share
14	Premium per share: i.              5,115 equity shares- Nil ii.             1,300 equity shares- Rs. 734.80/- per share iii.            6,250 equity shares-Rs.520.40/- per share
15	Total Issued shares after this issue:  83,46,44,020 (*)
16	Total Issued share capital after this issue: Rs. 83,46,44,020 /-
17	Details of any lock-in on the shares: NA
18	Date of expiry of lock-in:  NA
19	Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20	Details of listing fees, if payable: NA

(*) Total paid up capital after this issue: 83,46,43,020 equity shares of Re.1 each, aggregating to Rs. 83,46,43,020/- (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of non-payment of allotment money.)

FAQ

What did Dr. Reddy’s Laboratories (RDY) announce in the latest Form 6-K?

Dr. Reddy’s Laboratories allotted 12,665 new equity shares to employees following stock option exercises. The allotment, dated February 17, 2026, comes under the 2002 ESOP and 2007 ADR stock option schemes and slightly increases the company’s total issued share capital.

How many ESOP shares did Dr. Reddy’s Laboratories (RDY) issue and at what prices?

The company issued 12,665 equity shares of Re.1 each. Employees exercised 5,115 shares at Re.1, 1,300 shares at Rs. 735.80, and 6,250 shares at Rs. 521.40 per share under the existing employee stock option schemes.

What is Dr. Reddy’s total issued share capital after this ESOP allotment?

After the allotment, total issued shares are 83,46,44,020 and total issued share capital is Rs. 83,46,44,020. Paid-up capital stands at 83,46,43,020 equity shares of Re.1 each, reflecting a minor increase from the ESOP issuance.

Are the newly issued Dr. Reddy’s (RDY) ESOP shares identical to existing shares?

Yes, the company states that the new shares rank pari passu with existing equity shares. This means they carry the same rights as other outstanding shares, including voting and dividend rights, and are of the same Re.1 face value.

On which exchanges are Dr. Reddy’s Laboratories (RDY) shares listed?

Dr. Reddy’s shares are listed on BSE and NSE in India, while its American Depositary Receipts trade on the New York Stock Exchange and NSE IFSC Limited. The new equity shares relate to stock options under both domestic and ADR schemes.

Which employee stock option schemes were used for Dr. Reddy’s February 2026 allotment?

The allotment was made under Dr. Reddy’s Employees Stock Options Scheme, 2002 and the Employees ADR Stock Option Scheme, 2007. Eligible employees exercised options from these plans, leading to issuance of 12,665 fully paid equity shares of Re.1 each.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 71.4 KB